adesso Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de adesso de 20% y 7.9% por año respectivamente. Se prevé que el BPA crezca en un 20% al año. Se espera que la rentabilidad financiera sea de 13.8% en 3 años.
Información clave
20.0%
Tasa de crecimiento de los beneficios
20.01%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de IT | 12.3% |
| Tasa de crecimiento de los ingresos | 7.9% |
| Rentabilidad financiera futura | 13.77% |
| Cobertura de analistas | Good |
| Última actualización | 12 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • May 09
ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential
Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Actualización de narrativa • Apr 24
ADN1: Higher Discount Rate Will Create Long Term Opportunity
Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).Actualización de narrativa • Apr 10
ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential
Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.Artículo de análisis • Apr 07
Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality
When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...Artículo de análisis • Feb 12
The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...Artículo de análisis • Jan 22
adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Oct 19
Is There Now An Opportunity In adesso SE (ETR:ADN1)?
adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...Artículo de análisis • Sep 12
A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb
adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...Artículo de análisis • Sep 10
Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Artículo de análisis • May 25
Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business
adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...Artículo de análisis • Feb 25
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75
The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
Nueva narrativa • Feb 07
Ongoing IT Investments Will Transform Operations By Mid-2025
Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.Artículo de análisis • Dec 02
Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump
adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...Artículo de análisis • Nov 22
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...Artículo de análisis • Nov 17
adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target
The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...Artículo de análisis • Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Aug 28
It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks
The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...Artículo de análisis • May 21
adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Artículo de análisis • Apr 19
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70
The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...Artículo de análisis • Apr 18
Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Artículo de análisis • Apr 02
Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality
The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...Artículo de análisis • Mar 28
Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...Artículo de análisis • Mar 23
Is adesso SE (ETR:ADN1) Trading At A 44% Discount?
Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...Artículo de análisis • Mar 08
adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward
adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...Artículo de análisis • Dec 14
A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...Artículo de análisis • Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Jul 22
At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...Artículo de análisis • Jun 15
Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)
Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...Artículo de análisis • May 09
adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Artículo de análisis • Apr 22
What Does adesso SE's (ETR:ADN1) Share Price Indicate?
While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...Artículo de análisis • Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Jan 26
Returns On Capital At adesso (ETR:ADN1) Have Stalled
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Artículo de análisis • Jan 10
Calculating The Fair Value Of adesso SE (ETR:ADN1)
How far off is adesso SE ( ETR:ADN1 ) from its intrinsic value? Using the most recent financial data, we'll take a look...Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 1,942 | 47 | 54 | 121 | 5 |
| 12/31/2027 | 1,805 | 38 | 44 | 108 | 6 |
| 12/31/2026 | 1,632 | 27 | 38 | 91 | 6 |
| 3/31/2026 | 1,538 | 27 | 41 | 83 | N/A |
| 12/31/2025 | 1,489 | 18 | 43 | 86 | N/A |
| 9/30/2025 | 1,428 | 13 | 47 | 78 | N/A |
| 6/30/2025 | 1,384 | 12 | 54 | 85 | N/A |
| 3/31/2025 | 1,340 | 8 | 58 | 89 | N/A |
| 12/31/2024 | 1,298 | 3 | 81 | 118 | N/A |
| 9/30/2024 | 1,269 | 5 | 102 | 135 | N/A |
| 6/30/2024 | 1,225 | -1 | 94 | 129 | N/A |
| 3/31/2024 | 1,182 | -2 | 51 | 83 | N/A |
| 12/31/2023 | 1,140 | 3 | 43 | 77 | N/A |
| 9/30/2023 | 1,084 | 5 | -23 | 7 | N/A |
| 6/30/2023 | 1,037 | 12 | -28 | -1 | N/A |
| 3/31/2023 | 969 | 18 | 7 | 35 | N/A |
| 12/31/2022 | 901 | 29 | 12 | 36 | N/A |
| 9/30/2022 | 836 | 29 | 12 | 36 | N/A |
| 6/30/2022 | 769 | 28 | 12 | 33 | N/A |
| 3/31/2022 | 725 | 37 | 17 | 36 | N/A |
| 12/31/2021 | 678 | 48 | 30 | 48 | N/A |
| 9/30/2021 | 636 | 45 | 23 | 43 | N/A |
| 6/30/2021 | 600 | 46 | 23 | 37 | N/A |
| 3/31/2021 | 564 | 42 | 34 | 47 | N/A |
| 12/31/2020 | 524 | 21 | 54 | 65 | N/A |
| 9/30/2020 | 503 | 24 | 34 | 40 | N/A |
| 6/30/2020 | 484 | 19 | 34 | 43 | N/A |
| 3/31/2020 | 467 | 18 | 22 | 33 | N/A |
| 12/31/2019 | 451 | 17 | N/A | 22 | N/A |
| 9/30/2019 | 432 | 15 | N/A | 13 | N/A |
| 6/30/2019 | 412 | 13 | N/A | 3 | N/A |
| 3/31/2019 | 395 | 13 | N/A | 10 | N/A |
| 12/31/2018 | 378 | 14 | N/A | 18 | N/A |
| 9/30/2018 | 364 | 14 | N/A | 22 | N/A |
| 6/30/2018 | 351 | 14 | N/A | 26 | N/A |
| 3/31/2018 | 336 | 13 | N/A | 23 | N/A |
| 12/31/2017 | 322 | 11 | N/A | 20 | N/A |
| 9/30/2017 | 307 | 11 | N/A | 17 | N/A |
| 6/30/2017 | 292 | 11 | N/A | 13 | N/A |
| 3/31/2017 | 276 | 12 | N/A | 14 | N/A |
| 12/31/2016 | 261 | 12 | N/A | 15 | N/A |
| 9/30/2016 | 245 | 10 | N/A | 14 | N/A |
| 6/30/2016 | 229 | 7 | N/A | 14 | N/A |
| 3/31/2016 | 213 | 6 | N/A | 15 | N/A |
| 12/31/2015 | 197 | 5 | N/A | 17 | N/A |
| 9/30/2015 | 183 | 4 | N/A | 17 | N/A |
| 6/30/2015 | 169 | 4 | N/A | 16 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (20% al año) de ADN1 es superior a la tasa de ahorro (1.9%).
Beneficios vs. Mercado: Se prevé que los beneficios (20% al año) de ADN1 crezcan más rápidamente que el mercado German (17% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de ADN1 crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (7.9% al año) de ADN1 crezcan más rápidamente que los del mercado German (7.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.9% al año) de ADN1 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de ADN1 sea baja dentro de 3 años (13.8%).
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/17 00:10 |
| Precio de las acciones al final del día | 2026/05/15 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
adesso SE está cubierta por 11 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Daniel Großjohann | BankM AG |
| Wolfgang Specht | Berenberg |
| Finn Kemper | Hauck Aufhäuser Investment Banking |